HVT Medical

HVT Medical is developing a novel device called The Splitter to enable safer and more effective transcatheter aortic valve implantation (TAVI) procedures.

Medical Devices
Active
Seed Ramat Yishai, Israel Founded 2021
Last updated 2026-09-04
Total raised
—
Last: Undisclosed Round 2024-01
Stage
Seed
Founded
2021
Headcount
8
HQ
Ramat Yishai, Israel
Sector
Medical Devices
Website ↗LinkedIn ↗

About

HVT Medical, founded in 2021 in Israel, operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The company focuses on finding a solution for patients who are contraindicated for aortic valve implantation due to anatomical limitations. HVT Medical's Splitter device performs cusp splitting before a TAVI procedure to help reduce the risk of coronary occlusion. The device creates an intentional laceration or excision of the valve's cusp tissue using an advanced catheter equipped with a cutting head that mimics an alligator jaw. HVT Medical started as a portfolio company of the Israel MedicUp investment group, which focuses on advancing medtech and life science innovation in Israel.

Funding history · 2 rounds · — total

2 events/rounds · — Total Funding
Jan 2024
Aug 2021

Headcount over time

8 employees (2026-09) · 1 point
8 8 2026-09

Offices

Ramat Yishai, Israel · HQ / main office

Q&A

What is HVT Medical's primary focus?
HVT Medical focuses on developing solutions for patients who cannot undergo aortic valve implantation due to anatomical limitations.
What device is HVT Medical developing?
HVT Medical is developing a device called the Splitter, designed to be inserted in a catheterization procedure to modify the aortic valve and enable safe transcatheter valve implantation.
What is the purpose of the Splitter device?
The Splitter device performs cusp splitting before a TAVI procedure to help reduce the risk of coronary occlusion. It creates an intentional laceration or excision of the valve's cusp tissue using an advanced catheter with a cutting head.
When was HVT Medical founded?
HVT Medical was founded in January 2022.
How many employees does HVT Medical have?
HVT Medical has 8 employees, falling within the 1-10 employee bucket.
What is HVT Medical's primary sector?
HVT Medical's primary sector is Health Tech & Life Sciences.
What is HVT Medical's current product stage?
HVT Medical's product is currently in the beta stage.
What was HVT Medical's initial funding round?
In January 2022, HVT Medical secured a Seed round of funding, raising $1,500,000.

Team · 11

Dr. Yair Feld
Founder · CTO
Dr. Shlomo Lewkowicz
CEO
Dr. Arthur Kerner
Clinical Advisor
Tami Fogel
Senior Project Manager
Yiffat Halutzy Yagodovich
Operations Manager
Ayala Kobo, Ph.D.
Regulation, Validation and Risk Management Expert
Shlomit Valenstein
COO
Or Alon
System engineer
Dr. Isaac George
Advisor
Prof. Dr. Ole De Backer
Advisor
Professor David Hildick-Smith
Advisor

Sectors & technology

Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B

Tags

cardiologypatientshealthcaresurgerydigital-healthcarelife-sciencesmedical-deviceshospitalscatheters
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)